Literature DB >> 7841741

Successful treatment of aortic thrombosis after umbilical catheterization with tissue plasminogen activator.

J S Ahluwalia1, A W Kelsall, S Diederich, J M Rennie.   

Abstract

An infant presented 10 days after removal of a high umbilical arterial catheter with total occlusion of the distal abdominal aorta. Complete dissolution was achieved with a combination of i.v. tissue plasminogen activator and heparin. Ultrasound examination confirmed the diagnosis and subsequent resolution of the thrombus.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7841741     DOI： 10.1111/j.1651-2227.1994.tb18286.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN： 0803-5253            Impact factor:   2.299


  4 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature.

Authors:  J Hartmann; A Hussein; E Trowitzsch; J Becker; K H Hennecke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

3.  Clinical experience with alteplase in the management of intracardiac and major cardiac vessels thrombosis in pediatrics: a case series.

Authors:  Abdulrazaq S Al-Jazairi; Roaa A Al-Gain; Zead R Bulbul; Antoine J Cherfan
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

4.  Neonatal aortic arch thrombosis masquerading as coarctation of the aorta.

Authors:  B B Das; S Sahoo; D D Ivy
Journal:  Pediatr Cardiol       Date:  2003-11-03       Impact factor: 1.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.